CGP 37849
CAS: 127910-31-0
Ref. 3D-CFA91031
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
CGP 37849
Description:
CGP 37849 is an antagonist of the NMDA receptor. It has been shown to inhibit the transcriptional regulation of human dopamine-producing neurons in culture, with a potency that was 3-fold greater than that of MK801. CGP 37849 is also an antagonist of the NMDA receptor and can be used for the treatment of Parkinson's disease. This drug inhibits glutamate release from neurons and may act by blocking or reversing calcium channels or by inhibiting cation channels. CGP 37849 has been shown to increase locomotor activity and improve performance on a rotarod test in rats. The histological analysis showed neuronal death, which was prevented when CGP 37849 was administered prior to administration of neurotoxins.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
209.14 g/mol
Formula:
C6H12NO5P
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
